Fuel for the next generation of HealthTech ventures. Heran Partners is a leading investment fund focussing on MedTech, HealthTech and ventures that combine both.
Employees: 1-10
Portfolio 13
Date | Name | Website | Total Raised | Location |
01.12.2023 | Broken Str... | brokenstringbio.com | $15M | United Kin... |
06.06.2023 | icometrix | icometrix.com | $18M | - |
06.06.2023 | Amaron | amaron.be | - | Belgium, F... |
06.06.2023 | ONTOFORCE | ontoforce.com | - | Belgium, E... |
01.06.2023 | Hypervisio... | hypervisionsurgical.com | $8.1M | United Kin... |
04.04.2023 | ImmuneSpec | immunespec.com | - | Belgium, A... |
22.09.2022 | Landing pa... | aspect-analytics.com | - | - |
29.01.2020 | Lynxcare | lynx.care | $23.09M | Belgium, F... |
- | PharmaFlui... | pharmafluidics.com | $8.79M | Belgium, E... |
- | FOx BIOSYS... | foxbiosystems.com | $8.95M | Netherland... |
Show more
Persons 9
Date | First Name | Last Name | Title | Location | |||
- | Joris | Mortelmans | Partner / ... | linkedin.c... | - | - | - |
- | Filip | Maes | Scientific... | linkedin.c... | - | - | - |
- | Annie | Vereecken | Founding P... | linkedin.c... | - | - | - |
- | Herman | Verrelst | Founding P... | linkedin.c... | - | - | - |
- | Emke | Goijens | Office Man... | linkedin.c... | - | - | - |
- | Laurens | de Vries | Analyst | linkedin.c... | - | - | - |
- | Geoffrey | D'hondt | Investment... | linkedin.c... | - | - | - |
- | Raf | Roelands | Investment... | linkedin.c... | - | - | - |
- | Katleen | Vandersmis... | Managing P... | linkedin.c... | - | - | - |
News 31
Date | Title | Description |
16.02.2024 | Laurens de Vries joins HERAN Partners as Analyst | Based on a shared passion for innovations on the intersection of medicine, engineering, and business, Laurens found his way to HERAN Partners. He understands that the road to market for medical ventures is paved with obstacles and that even... |
19.09.2023 | 13th Investment for HERAN Partners: Broken String Biosciences (UK) | Cambridge, UK: Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, announced that it has closed a $15m Series A investment round, co-led ... |
14.09.2023 | Thirona secures EUR 7,5m via investment round and EIC grant | Nijmegen, the Netherlands – Thirona, a global company specialized in advanced analysis of thoracic CT images with artificial intelligence, is thrilled to announce the successful completion of its new investment. The Company has secured EUR ... |
05.09.2023 | FOx BIOSYSTEMS appoints Dr. Mark Truesdale as CEO | Diepenbeek, Belgium, September 5th, 2023 |
01.06.2023 | HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform | Hypervision Surgical, a London-based venture building an advanced surgical imaging and data analytics platform, announced the successful completion of an oversubscribed seed funding round, raising GBP 6,5M. By harnessing AI and clinical edg... |
14.04.2023 | Discover how a sound collaboration between a start-up and a Venture Capital fund drives innovation in healthcare: FOx Biosystems case study | Data processing, speed, and efficiency are of key importance in the field of pharmacological research. The importance of these factors was evident during the development of the first COVID-19 vaccines. With their White FOx technology, FOx B... |
24.03.2023 | HERAN Partners announces EUR 1,2m investment in ImmuneSpec to accelerate their advanced immunopeptidomics platform | You can find the original press release by ImmuneSpec here. |
13.03.2023 | 6 questions for SMEs and start-ups looking to become more sustainable: 'Find the right balance between workload and impact' | You can find the original interview (NL) in Trends magazine here. |
13.01.2023 | FOx BIOSYSTEMS raises €5,8 million in a Series B-round | Diepenbeek, Belgium |
20.12.2022 | FOx BIOSYSTEMS receives €2,5 million EIC grant |
Show more
Mentions in press and media 6
Date | Title | Description |
18.09.2023 | UK’s Broken String Biosciences raises €14M to develop, commercialise its INDUCE-seq tech: Know more | Read this article in: Cambridge-based Broken String Biosciences, a genomics company focused on creating safer cell and gene therapies, announced on Monday that it has raised $15M (approximately €14M) in a Series A round of funding. The inve... |
06.09.2023 | How Pitango VC Is Planning to Invest Its New $175M Health Tech Fund | Pitango Venture Capital, one of the largest venture capital firms in Israel, announced on Wednesday the closing of a new $175 million healthcare fund. The fund, named Pitango HealthTech II, is a sequel to Pitango’s first healthcare-dedicate... |
01.06.2023 | HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform | Hypervision Surgical, a London-based venture building an advanced surgical imaging and data analytics platform, announced the successful completion of an oversubscribed seed funding round, raising GBP 6,5M. By harnessing AI and clinical edg... |
24.03.2023 | HERAN Partners announces EUR 1,2m investment in ImmuneSpec to accelerate their advanced immunopeptidomics platform | You can find the original press release by ImmuneSpec here. |
21.06.2022 | Belgian health tech Lynxcare unlocks €20 million to boost clinical insights for doctors | Belgian AI-powered clinical data platform LynxCare has raised €20 million in funding to accelerate the international rollout of its technology. The Series A investment was led by Swiss healthtech investor MTIP and joined by Elaia and the co... |
- | Belgian health tech Lynxcare unlocks €20 million to boost clinical insights for doctors | Belgian AI-powered clinical data platform LynxCare has raised €20 million in funding to accelerate the international rollout of its technology. The Series A investment was led by Swiss healthtech investor MTIP and joined by Elaia and the co... |